BiKi Technologies addresses big challenges in computational drug design including koff prediction and full flexibility in protein-ligand binding. BiKi’s strategic assets are based on molecular dynamics simulations and related approaches, such as enhanced sampling for free energy and kinetics estimations. Further algorithms developed by BiKi Technologies comprise innovative clustering tools based on machine learning. A multidisciplinary team of Software Engineers and Developers, Computational Chemists and Biochemists bring together knowledge and expertise to maintain and support new molecular dynamics based products for drug design and discovery.
Legal information
BiKi TECHNOLOGIES s.r.l.: costituita il 7 Maggio 2014, in via XX Settembre 1/10, 16121 Genova Italia presso il notaio Dott. Angelo Noli.
Sede Legale: Via XX Settembre, n. 33/10, 16121 Genova, Italia
PEC: biki[at]legalmail.it
Oggetto sociale: Sviluppo, Produzione e Commercializzazione di Prodotti e Servizi ad alto contenuto tecnologico.